Samsung Biologics and LegoChem enter ADC development deal
Samsung Biologics has entered into a strategic partnership with LegoChem Biosciences to advance ADC programmes aimed at treating solid tumours.
Legochem Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Legochem Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Legochem Bioscience Today - Breaking & Trending Today
Samsung Biologics partners with LegoChem Biosciences for ADC development and manufacturing
- Samsung Biologics to develop and manufacture antibody for ADC candidate - Latest deal comes as Samsung Biologics is on track to complete construction of an ADC facility this year INCHEON, South Korea, Feb. 7, 2024
Source: benzinga.com
Orion seeks new growth engine via majority stake in LegoChem Biosciences
On Monday, the confectionery and beverage company announced that it would invest 550 billion won ($414 million) to acquire a 25 percent stake in LegoChem. It will secure the stake by participating in LegoChem’s paid-in capital increase and acquiring shares from major shareholders. The payment is due on March 29.
Source: koreatimes.co.kr